AG真人官方

AbCellera to Participate at Upcoming Investor Conferences in September

VANCOUVER, British Columbia--(BUSINESS WIRE)-- (Nasdaq: ABCL) today announced that the Company will participate in the following investor conferences:

• Wells Fargo Healthcare Conference, September 3-5, 2025
• Morgan Stanley Annual Global Healthcare Conference, September 8-10, 2025

Visit for additional information.

About AbCellera Biologics Inc.

(Nasdaq: ABCL) is a clinical-stage biotechnology company focused on discovering and developing antibody-based medicines in the areas of endocrinology, women's health, immunology, and oncology. For more information, please visit .

View source version on businesswire.com:

Inquiries

Media: Tiffany Chiu; [email protected], +1(236)521-6774

Partnering: Murray McCutcheon, Ph.D.; [email protected], +1(604)559-9005

Investor Relations: Peter Ahn; [email protected], +1(778)729-9116

Source: AbCellera Biologics Inc.